StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Hydrochloric Acid → 4-(3-Aminoazetidin-1-yl)-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5,5-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one

HRID 536532
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 536532
Cl.C(OC(=O)[NH:8][CH:9]1[CH2:12][N:11]([C:13]2[C:14]3[C:38]([CH3:40])([CH3:39])[C:37](=[O:41])[NH:36][C:15]=3[N:16]=[C:17]([C:19]3[C:27]4[C:22](=[N:23][CH:24]=[CH:25][CH:26]=4)[N:21]([CH2:28][C:29]4[CH:34]=[CH:33][CH:32]=[CH:31][C:30]=4[F:35])[N:20]=3)[N:18]=2)[CH2:10]1)(C)(C)C>C(OCC)C>[NH2:8][CH:9]1[CH2:10][N:11]([C:13]2[C:14]3[C:38]([CH3:39])([CH3:40])[C:37](=[O:41])[NH:36][C:15]=3[N:16]=[C:17]([C:19]3[C:27]4[C:22](=[N:23][CH:24]=[CH:25][CH:26]=4)[N:21]([CH2:28][C:29]4[CH:34]=[CH:33][CH:32]=[CH:31][C:30]=4[F:35])[N:20]=3)[N:18]=2)[CH2:12]1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

4

Edukt 2

HCID 313Hydrochloric AcidHCID 71290302tert.-Butyl-(1-{2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5,5-dimethyl-6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl}azetidin-3-yl)carbamate

Produkt 1

HCID 712857714-(3-Aminoazetidin-1-yl)-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5,5-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 3283
Diethyl Ether
Lösungsmittel

Versuchsvorschrift

0.66 ml of a 2N solution of hydrogen chloride in diethyl ether was added to 81 mg (0.13 mmol; purity 91%) of tert.-butyl-(1-[2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5,5-dimethyl-6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]azetidin-3-yl)carbamate (example 62A) and it was stirred for 4 h at room temperature. The reaction solution was concentrated by evaporation and purified twice by preparative HPLC (acetonitrile/water (+0.1% trifluoroacetic acid) gradient). The concentrated fractions were dissolved in dichloromethane and washed twice with saturated aqueous sodium hydrogen carbonate solution. The combined aqueous phases were extracted twice with dichloromethane. The combined organic phases were dried over sodium sulphate, filtered and concentrated by evaporation. 31 mg (49% of theor.) of the target compound was obtained.

Aufarbeitung

  1. concentrationThe reaction solution was concentrated by evaporation
  2. custompurified twice by preparative HPLC (acetonitrile/water (+0.1% trifluoroacetic acid) gradient)
  3. dissolutionThe concentrated fractions were dissolved in dichloromethane
  4. washwashed twice with saturated aqueous sodium hydrogen carbonate solution
  5. extractionThe combined aqueous phases were extracted twice with dichloromethane
  6. dry with materialThe combined organic phases were dried over sodium sulphate
  7. filtrationfiltered
  8. concentrationconcentrated by evaporation
  9. custom31 mg (49% of theor.) of the target compound was obtained

Quellen und Nachweise

ORD-Eintrag
ord-50f58b52677f4bf184d8420b134ccb3b
Quelldatensatz
uspto-grants-2014_10
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08859569B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion